Literature DB >> 2764373

Hypoxic and hypercapnic ventilatory responses in awake children with congenital central hypoventilation syndrome.

J Y Paton1, S Swaminathan, C W Sargent, T G Keens.   

Abstract

Congenital central hypoventilation syndrome (CCHS) has been thought to be a disorder of central chemoreceptor responsiveness. Previous studies in CCHS have shown decreased or absent ventilatory responsiveness to both hypercarbia and hypoxia. However, hypoxic responsiveness during wakefulness has not been systematically studied. We studied hypoxic and hypercapnic ventilatory responses during wakefulness in five children with CCHS (6 to 11 yr of age). To measure the hypercapnic response, the children rebreathed a hyperoxic hypercapnic mixture until PaCO2 reached 56 to 69 mm Hg. For the hypoxic response, the children rebreathed a hypoxic gas mixture, at mixed venous PCO2, until SaO2 had fallen to less than 78%. We found that the ventilatory responses to hypercapnia and hypoxia were very variable (linear correlation coefficients ranging from -0.44 to +0.63 for hypercapnic responses and from -0.15 to +0.77 for hypoxic responses), with no significant change from baseline in response to either stimulus. There was no evidence of progressive ventilatory stimulation despite increasing stimulus. Additionally, these children had no subjective sensation of dyspnea or discomfort. This establishes that hypoxic and hypercapnic ventilatory control is absent during wakefulness. Chemoreceptor control (peripheral and central) is, therefore, defective in all states in children with CCHS. We speculate that the defect in CCHS lies in central integration of the central and peripheral chemoreceptor signals.

Entities:  

Mesh:

Year:  1989        PMID: 2764373     DOI: 10.1164/ajrccm/140.2.368

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  29 in total

1.  Adult With PHOX2B Mutation and Late-Onset Congenital Central Hypoventilation Syndrome.

Authors:  Ajay S Kasi; Sheila S Kun; Thomas G Keens; Iris A Perez
Journal:  J Clin Sleep Med       Date:  2018-12-15       Impact factor: 4.062

2.  Intelligent volume-assured pressured support (iVAPS) for the treatment of congenital central hypoventilation syndrome.

Authors:  Abdullah Khayat; Debra Medin; Faiza Syed; Theo J Moraes; Saadoun Bin-Hasan; Indra Narang; Suhail Al-Saleh; Reshma Amin
Journal:  Sleep Breath       Date:  2017-02-11       Impact factor: 2.816

3.  Reduced caudate nuclei volumes in patients with congenital central hypoventilation syndrome.

Authors:  R Kumar; R Ahdout; P M Macey; M A Woo; C Avedissian; P M Thompson; R M Harper
Journal:  Neuroscience       Date:  2009-07-24       Impact factor: 3.590

Review 4.  The control of breathing with reference to congenital central hypoventilation syndrome.

Authors:  F Child; J Couriel
Journal:  J R Soc Med       Date:  1998-09       Impact factor: 5.344

5.  Some congenital diseases may just show up later.

Authors:  Manju S Hurvitz; Rakesh Bhattacharjee
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

Review 6.  Pathogenesis of central and complex sleep apnoea.

Authors:  Jeremy E Orr; Atul Malhotra; Scott A Sands
Journal:  Respirology       Date:  2016-10-31       Impact factor: 6.424

Review 7.  Central respiratory chemoreception.

Authors:  Patrice G Guyenet; Ruth L Stornetta; Douglas A Bayliss
Journal:  J Comp Neurol       Date:  2010-10-01       Impact factor: 3.215

8.  Diffusion tensor imaging demonstrates brainstem and cerebellar abnormalities in congenital central hypoventilation syndrome.

Authors:  Rajesh Kumar; Paul M Macey; Mary A Woo; Jeffry R Alger; Ronald M Harper
Journal:  Pediatr Res       Date:  2008-09       Impact factor: 3.756

9.  Congenital central hypoventilation syndrome.

Authors:  P G Samdani; Vinit Samdani; Mahesh Balsekar; Akhil Goel
Journal:  Indian J Pediatr       Date:  2007-10       Impact factor: 1.967

10.  Hippocampal volume reduction in congenital central hypoventilation syndrome.

Authors:  Paul M Macey; Christopher A Richard; Rajesh Kumar; Mary A Woo; Jennifer A Ogren; Christina Avedissian; Paul M Thompson; Ronald M Harper
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.